David M Mott's Net Worth
David M Mott's net worth is estimated to be at least $36,634,925.66 as of 02/06/2025. CoreStreet's estimation of David M Mott's net worth is based on their sale of stock and current holding of stock.
David M Mott is Director at Ardelyx Inc. They have executed at least 17 trades of stock as per SEC Form 4 filings. Their most recent trade was for 199,000 units of ARDX stock on 01/21/2025. Their biggest sale was on 09/23/2021 when they sold 24,961 units of Novavax Inc stock for $6,312,636.90. They typically trade 1 times per year.
Total value of insider buys:
- $28,949,621.24
Total value of insider sells:
- $7,685,304.42
Most recent insider trade:
- Jan. 21, 2025
David M Mott's Insider Trading History
| Ardelyx Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 21, 2025 | Director | 199,000 | $4.99 | Buy | $993,010.00 |
Dec. 19, 2024 | Director | 213,300 | $4.67 | Buy | $996,111.00 |
| Imara Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 22, 2022 | Director | 65,817 | $1.56 | Buy | $102,674.52 |
Feb. 18, 2022 | Director | 50,398 | $1.30 | Buy | $65,517.40 |
Feb. 16, 2022 | Director | 11,779 | $1.20 | Buy | $14,134.80 |
Feb. 14, 2022 | Director | 8,500 | $1.18 | Buy | $10,030.00 |
Feb. 10, 2022 | Director | 8,753 | $1.29 | Buy | $11,291.37 |
| Novavax Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 23, 2021 | Director | 24,961 | $252.90 | Sell | $6,312,636.90 |
| Epizyme Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 25, 2021 | Director | 28,231 | $7.98 | Buy | $225,283.38 |
June 26, 2020 | Director | 62,019 | $16.03 | Buy | $994,164.57 |
June 26, 2019 | Director | 104,944 | $13.08 | Sell | $1,372,667.52 |
Oct. 5, 2018 | Director | 416,667 | $9.00 | Buy | $3,750,003.00 |
Sept. 18, 2017 | Director | 200,000 | $15.25 | Buy | $3,050,000.00 |
Jan. 12, 2016 | Director | 1,111,111 | $9.00 | Buy | $9,999,999.00 |
June 5, 2013 | Director | 400,000 | $15.00 | Buy | $6,000,000.00 |
| Adaptimmune Therapeutics Plc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 26, 2018 | Director | 571,164 | $1.90 | Buy | $1,085,211.60 |
March 22, 2018 | Director | 869,574 | $1.90 | Buy | $1,652,190.60 |